Top Stories
Latest Coverage
Current Status of Immunotherapy for Bladder Cancer: From BCG to Precision Combination Therapy
Bladder cancer is one of the most common malignancies of the urinary system. A substantial proportion of patients are...
Bladder cancer is one of the most common malignancies of the urinary system. A substantial proportion of patients are...
Are Women More Prone to Thyroid Cancer? Causes and Prevention Explained
In recent years, the incidence of thyroid cancer has been rising globally. One notable feature is that women are affe...
In recent years, the incidence of thyroid cancer has been rising globally. One notable feature is that women are affe...
From Health Checkups to Cancer Treatment: China’s Medical Travel Market Is Rapidly Expanding
From Health Checkups to Cancer Treatment: China’s Medical Travel Market Is Rapidly Expanding
From Health Checkups to Cancer Treatment: China’s Medical Travel Market Is Rapidly Expanding
Where Pancreatic Cancer Develops Matters: Understanding Pancreatic Head Cancer vs. Body and Tail Cancer
Pancreatic cancer is a malignant tumor that develops in the pancreas. While many people know that pancreatic cancer c...
Pancreatic cancer is a malignant tumor that develops in the pancreas. While many people know that pancreatic cancer c...
New Progress in First-Line Treatment of HER2-Positive Breast Cancer: Trastuzumab Deruxtecan Plus Pertuzumab Approved
On August 12, 2026, Daiichi Sankyo announced that trastuzumab deruxtecan (T-DXd, brand name: Enhertu), a HER2-targete...
On August 12, 2026, Daiichi Sankyo announced that trastuzumab deruxtecan (T-DXd, brand name: Enhertu), a HER2-targete...
Which Pancreatic Cancer Patients May Benefit from Immunotherapy? An Analysis of Biomarkers and Treatment Options
Pancreatic cancer is one of the common malignant tumors of the digestive system, with pancreatic ductal adenocarcinom...
Pancreatic cancer is one of the common malignant tumors of the digestive system, with pancreatic ductal adenocarcinom...
